Smoking CessationNCT07210567
Mindfulness-based Ecological Momentary Intervention for Smoking Cessation Among Cancer Survivors
A study testing Mindfulness and Quitline in people with Smoking Cessation, run by Rutgers, The State University of New Jersey at 1 site in United States.
Trial summary
The purpose of the study is to develop a new quit-smoking treatment among individuals with a cancer diagnosis using a smartphone app. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Smoking Cessation
- What is being tested?
- Mindfulness and Quitline
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 50 participants
- Where
- 1 siteUnited States
- Study dates
- 27 Jan 2026to 31 Dec 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- ≥18 years old
- smoked ≥1 cigarette per day (even one or two puffs) within the past 30 days
- having been diagnosed with cancer
- being motivated to quit in the next 30 days
- having a valid home address and functioning phone number
- being able to read, write, and speak English
- having a smartphone that allows installation of the app
- willingness to download the app
Who cannot join
- being enrolled in a smoking cessation program
- current use of smoking cessation medications
- evidence of current psychosis
- current/planning pregnancy or lactation
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
Institute for Nicotine & Tobacco Studies
New Brunswick, New Jersey, 08901
About this study
The purpose of the study is to develop a new quit-smoking treatment among individuals with a cancer diagnosis using a smartphone app.
Read the detailed description
The study aims to test the feasibility and acceptability of the smartphone app we developed in conjunction with face-to-face brief cessation counseling and nicotine replacement therapy in a two-arm randomized controlled trial.
- Conditions
- Smoking Cessation
- Being tested
- Mindfulness, Quitline
- Keywords
- quit smoking, cancer survivors
- Medical subject headings
- Smoking Cessation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
MindfulnessBehavioural
Participants will complete 4 counseling sessions (30 minutes), download and use a smartphone app for 4 weeks, complete 4 online surveys (baseline, quit date, end of treatment, and 3-month follow-up), and a brief phone call at the end of treatment to provide feedback. Participants will use the app every day to complete daily diaries and ecological momentary assessments (EMAs), receive brief mindful skills, and practice formal mindfulness meditations (5-30 minutes). Participants will also be provided with nicotine patches.
QuitlineBehavioural
Participants will be referred to Quitline to receive standard care smoking cessation treatment, including counseling and nicotine patches. Participants will complete 4 online surveys (baseline, quit date, end of treatment, and 3-month follow-up) and a brief phone call at the end of treatment to provide feedback. Participants will use the app every day to complete daily diaries.
| Study group | Role | What they receive |
|---|---|---|
| Mindfulness | Experimental | Participants will receive brief counseling, nicotine replacement therapy, and intervention content delivered via the app. Receives: Behavioral: Mindfulness |
| Quitline | Active comparator | Participants will be referred to Quitline to receive standard care for smoking cessation. Receives: Behavioral: Quitline |
What is being measured
The primary outcome is the main question the study is designed to answer.
System Usablity Scale
Perceived usability and learnability of the app will be measured on a 5-point scale (1=strongly disagree; 5=strongly agree).
Measured: End of Treatment at 4 Weeks
Client Satisfaction Questionnaire
Perceived satisfaction with the treatment will be assessed on a 4-point scale (1=very dissatisfied; 4=very satisfied).
Measured: End of Treatment at 4 Weeks
Percentage of Participants That Completed Questionnaires
Completion of follow-up assessment will be calculated.
Measured: 3-month follow-up
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted7 Oct 2025
- Study start27 Jan 2026
- Primary completion31 Dec 2027 (estimated)
- Study completion31 Dec 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Smoking CessationStudies of the same condition, open and under way.
- More trials run by Rutgers, The State University of New JerseyThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 50 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Rutgers, The State University of New Jersey
- Sponsor type
- University, hospital or other
- Collaborators
- National Cancer Institute (NCI)
- Responsible party
- Principal investigator, Min-Jeong Yang, Ph.D., Rutgers, The State University of New Jersey
- Investigators
- Min-Jeong Yang, PhD, Principal investigator, Rutgers, The State University of New Jersey
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07210567
- Sponsor's protocol ID
- Pro2024002019
- Other IDs
- R00CA271040
- Status last verified
- May 2026
- First submitted
- 17 Sep 2025
- Last updated
- 4 May 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 4 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Mindfulness-based Ecological Momentary Intervention for Smoking Cessation Among Cancer Survivors
- ClinicalTrials.gov ID
- NCT07210567
- Acronym / sponsor ID
- Pro2024002019
- Conditions
- Smoking Cessation
- Keywords
- quit smoking, cancer survivors
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 50 participants (estimated)
- Lead sponsor
- Rutgers, The State University of New JerseyUniversity, hospital or other
- Collaborators
- National Cancer Institute (NCI)
- Study start
- 27 Jan 2026 (actual)
- Primary completion
- 31 Dec 2027 (estimated)
- Study completion
- 31 Dec 2028 (estimated)
- First posted
- 7 Oct 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of the study is to develop a new quit-smoking treatment among individuals with a cancer diagnosis using a smartphone app.
Detailed description
The study aims to test the feasibility and acceptability of the smartphone app we developed in conjunction with face-to-face brief cessation counseling and nicotine replacement therapy in a two-arm randomized controlled trial.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Mindfulness | Experimental | Behavioral: MindfulnessParticipants will receive brief counseling, nicotine replacement therapy, and intervention content delivered via the app. |
| Quitline | Active comparator | Behavioral: QuitlineParticipants will be referred to Quitline to receive standard care for smoking cessation. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (8 listed)
- ≥18 years old
- smoked ≥1 cigarette per day (even one or two puffs) within the past 30 days
- having been diagnosed with cancer
- being motivated to quit in the next 30 days
- having a valid home address and functioning phone number
Key exclusion criteria (4 listed)
- being enrolled in a smoking cessation program
- current use of smoking cessation medications
- evidence of current psychosis
- current/planning pregnancy or lactation
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| MindfulnessParticipants will complete 4 counseling sessions (30 minutes), download and use a smartphone app for 4 weeks, complete 4 online surveys (baseline, quit date, end of treatment, and 3-month follow-up), and a brief phone call at the end of treatment to provide feedback. Participants will use the app every day to complete daily diaries and ecological momentary assessments (EMAs), receive brief mindful skills, and practice formal mindfulness meditations (5-30 minutes). Participants will also be provided with nicotine patches. | Behavioural | Mindfulness |
| QuitlineParticipants will be referred to Quitline to receive standard care smoking cessation treatment, including counseling and nicotine patches. Participants will complete 4 online surveys (baseline, quit date, end of treatment, and 3-month follow-up) and a brief phone call at the end of treatment to provide feedback. Participants will use the app every day to complete daily diaries. | Behavioural | Quitline |
Primary outcome
System Usablity Scale
Time frame: End of Treatment at 4 Weeks
Perceived usability and learnability of the app will be measured on a 5-point scale (1=strongly disagree; 5=strongly agree).
Client Satisfaction Questionnaire
Time frame: End of Treatment at 4 Weeks
Perceived satisfaction with the treatment will be assessed on a 4-point scale (1=very dissatisfied; 4=very satisfied).
Percentage of Participants That Completed Questionnaires
Time frame: 3-month follow-up
Completion of follow-up assessment will be calculated.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 May 2026.
- Individual participant dataSharing planned: No
Related trials for Smoking Cessation
Enrolling by invitationObservational study
Using Smartwatches to Monitor Smoking in Real-life Situations
Smoking
Not yet recruitingObservational study
PROMETHEE: A Shared Interregional Tele-Tobacco Cessation Platform Embedded Within the IMPULSION Lung Cancer Screening Program
Smoking Cessation, Lung Cancer Screening
Not yet recruiting
Impacto 2.0: Mobile Smoking Cessation Across Texas
Cigarette Smoking, Smoking Cessation
Not yet recruiting
Smoking Cessation Program for Lao People With HIV
Smoking Cessation, HIV
RecruitingPhase 3
Studying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT)
Smoking Cessation
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Min-Jeong Yang, PhD principal investigator
Rutgers, The State University of New Jersey
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Mindfulness and Quitline in people with Smoking Cessation, run by Rutgers, The State University of New Jersey at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 4 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Rutgers IRB/Human Research Protection Program (9739723608, irboffice@research.rutgers.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
System Usablity Scale (time frame: End of Treatment at 4 Weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 May 2026.